
Methods: Antibiotic prescriptions for Group A Streptococcal pharyngitis were tabulated by provider from Sep. 1, 2011 – Aug 31, 2012. On Oct. 5, 2012, the coded spreadsheet, the Guideline, and a cover letter discussing our network results, a need for better antibiotic stewardship, and each provider's key were mailed to each provider for review. We characterized antibiotics as 1) the most narrow spectrum therapy (pen VK, Bicillin, amoxicillin), 2) an alternative first generation cephalosporin (cefadroxil, cephalexin), and 3) effective, but too broad for the purposes of antimicrobial stewardship (amoxicillin/clavulanate, azithromycin, cefaclor, cefdinir, cefixime, cefpodoxime, cefprozil, ceftibuten, cefuroxime, ciprofloxacin, clarithromycin, erythromycin), which we defined as our target for better stewardship. We compared the data for the subsequent 6 months.
Results:
Review Period |
Total Prescriptions for Streptococal Pharyngitis |
Most Narrow Spectrum Antibiotic (Penicillin or Amoxicilin) |
First Generation Cephalosporin (cefadroxil, cephalexin) |
Target for Better Antimicrobial Stewardship (All Other Effective Antibiotics) |
Sep.1,2011-Aug.31,2012 |
23,345 |
10,178 (44%) |
2,121 (9%) |
10,916 (47%) |
Oct.15,2012-Apr.15,2013 |
8,205 |
5,097 (62%) |
837 (10%) |
2,243 (27%) |
Conclusion: Reporting of comparative antibiotic prescribing patterns to providers reduced network prescriptions for streptococcal pharyngitis that were effective, but too broad for the purposes of antimicrobial stewardship from 47 to 27% for 6 months. More feedback is planned.

M. Mazade, None